Pulmonology
Respiraphen®
Registration certificate:
INN:
Ипратропия бромид + Фенотерол
Release form:
Solution for inhalation
Therapeutic Area:
Pulmonology
Pharmacotherapeutic Group:
Combined bronchodilator (β-2-selective adrenomimetic+m-holinoblocker)
Conditions for dispensing:
On prescription
Packaging:

Indications for Use:

Symptomatic treatment of chronic obstructive respiratory diseases with reversible airway obstruction, such as bronchial asthma, chronic obstructive pulmonary disease (COPD), and chronic obstructive bronchitis with or without emphysema.

This medication is included in the List of Essential Medicines.

Quality control
at all stages of production